News

Analyst Highlights ‘Game Changer’ Catalyst for Eli Lilly (LLY)
Talking about Morgan Stanley’s bullish call on Eli Lilly and Company (NYSE:LLY), Kevin Simpson, Capital Wealth Planning founder and CIO, said that he agrees with the call and thinks the company’s ...
Fierce Biotech11h
MapLight raises $373M to plot phase 2 journey for would-be rival to BMS' Cobenfy
MapLight Therapeutics has raised a $372.5 million series D round, clearing the biotech to chart a course through phase 2 for ...
Eli Lilly (LLY) Gets Price Target Boost as Analysts See Strong Mounjaro, Zepbound Sales
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
Eli Lilly’s (LLY) Kisunla Gets FDA Approval for Safer Alzheimer’s Dosing Schedule
Eli Lilly & Company (NYSE:LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...